sales@businessmarketinsights.com     UK: +442081254005
   

Europe Small Molecule Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Country

Code: TIPRE00013000 | Pages: 138 | Industry: Pharmaceuticals | Date: Aug 2020
Covid

Market Introduction

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery. When the biological target is well defined and understood, the rational design of small molecule ligands is possible. In the recent years, the small molecules have witnessed significant attention over biologics, as there is an increasing demand for these drugs.

Market Overview and Dynamics

The Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The market is expected to grow with a CAGR of 9.0% from 2020 to 2027. Factors such as growing demand for R&D from contract organizations along with the growing developments and start-ups in small molecules drug delivery market is likely to propel the growth of the market. However, high cost associated with drug development is the major factor hindering the market growth.

Key Market Segments

In terms of therapeutic area, the oncology segment held the larger share of the market in 2019. However, rare diseases is anticipated to register the higher CAGR in the market during the forecast period. Based on process/phase, in 2019, the lead generation and refinement segment held the larger share of the market, however, target discovery segment is anticipated to register the higher CAGR in the market during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Europe small molecule drug delivery market included in the report are European Investment Bank (EIB), World Health Organization (WHO), National Center for Biotechnology Information (NCBI), and National Heart, Lung, and Blood Institute (NHLBI)

Reasons to buy the report

  • To understand the Europe small molecule drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe small molecule drug delivery market
  • Efficiently plan M&A and partnership deals in Europe small molecule drug delivery market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of Europe small molecule drug delivery market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe

Europe Small Molecule Drug Delivery Market –

By Therapeutic Area

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Orthopedics
  • Immunology
  • Rare Diseases
  • Other Therapeutic Areas

By Process/Phase

  • Target Discovery
  • Target Validation
  • Lead Generation and Refinement
  • Preclinical Development

By Country

  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

 

Company Profiles

  • Merck KGaA
  • GlaxoSmithKline plc
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Allergan Plc
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Small Molecule Drug Discovery Market – By Therapeutic Area

1.3.2        Europe Small Molecule Drug Discovery Market – By Process/Phase

1.3.3        Europe Small Molecule Drug Delivery Market– By Region

2.          Small Molecule Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Small Molecule Drug Delivery – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Europe

4.3        Expert Opinion

5.          Europe Small Molecule Drug Delivery Market – Industry Dynamics

5.1        Key Drivers

5.1.1        Growing Demand for R&D from Contract Organizations

5.1.2        Growing Developments and Start-Ups in Small Molecules Drug Delivery Market

5.2        Market Restraints

5.2.1        High Cost of Drug Development

5.3        Market Opportunities

5.3.1        Growing Small Molecule Drug Delivery Product Approvals and Collaborations

5.4        Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5        Impact analysis

6.          Small Molecule Drug Delivery Market – Regional Analysis

6.1        Europe Small Molecule Drug Delivery Market Revenue Forecast And Analysis

6.2        Market Positioning of Key Players

7.          Small Molecule Drug Discovery Market–  By Therapeutic Area

7.1        Overview

7.2        Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

7.3        Oncology

7.3.1        Overview

7.3.2        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.4        Central Nervous System

7.4.1        Overview

7.4.2        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

7.5        Cardiovascular

7.5.1        Overview

7.5.2        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.6        Respiratory

7.6.1        Overview

7.6.2        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.7        Orthopedics

7.7.1        Overview

7.7.2        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.8        Immunology

7.8.1        Overview

7.8.2        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.9        Rare Diseases

7.9.1        Overview

7.9.2        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.10     Other Therapeutic Areas

7.10.1     Overview

7.10.2     Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

8.          Small Molecule Drug Discovery Market –  By Process/Phase

8.1        Overview

8.2        Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

8.3        Target Discovery

8.3.1        Overview

8.3.2        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Target Validation

8.4.1        Overview

8.4.2        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.5        Lead Generation and Refinement

8.5.1        Overview

8.5.2        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Preclinical Development

8.6.1        Overview

8.6.2        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027  (US$ Million)

9.          Small Molecule Drug Discovery Market – Geographic Analysis

9.1        Europe: Small Molecule Drug Discovery Market

9.1.1        Overview

9.1.2        Europe: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Millions)

9.1.3        Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018–2027 (USD Millions)

9.1.4        Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.1.5.1         Germany: Small Molecule Drug Discovery Market

9.1.5.1.1         Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.1.2         Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.1.3         Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.2         United Kingdom: Small Molecule Drug Discovery Market

9.1.5.2.1         United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.2.2         United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.2.3         United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.3         France: Small Molecule Drug Discovery Market

9.1.5.3.1         France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.3.2         France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.3.3         France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.4         Italy: Small Molecule Drug Discovery Market

9.1.5.4.1         Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.4.2         Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.4.3         Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.5         Spain: Small Molecule Drug Discovery Market

9.1.5.5.1         Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.5.2         Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.5.3         Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

10.       Impact Of COVID-19 Pandemic On Europe Small Molecule Drug Delivery Market

10.1     Europe: Impact Assessment of COVID-19 Pandemic

11.       Small Molecule Drug Discovery Market –Company Profiles

11.1     Merck KGaA

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     GlaxoSmithKline plc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     AstraZeneca

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Boehringer Ingelheim International GmbH

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     Allergan Plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

LIST OF TABLES

Table 1.            Europe Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 2.            Europe Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 3.            Germany Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 ( USD Millions)

Table 4.            Germany Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 5.            United Kingdom Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 6.            United Kingdom Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 7.            France Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 8.            France Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 9.            Italy Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 10.         Italy Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 11.         Spain Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 12.         Spain Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 13.         Glossary of Terms, Small Molecule Drug Discovery Market

 

LIST OF FIGURES

Figure 1.          Small Molecule Drug Delivery Market Segmentation

Figure 2.          Small Molecule Drug Delivery Segmentation – By Region

Figure 3.          Europe Small Molecule Drug Delivery Market Overview

Figure 4.          The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate

Figure 5.          Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.          Europe PEST Analysis

Figure 7.          Small molecule drug discovery Market Impact Analysis of Driver and Restraints

Figure 8.          Europe Small Molecule Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.          Market Positioning of Key Players In Europe Small Molecule Drug Discovery Market

Figure 10.        Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

Figure 11.        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 12.        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 13.        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 14.        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 15.        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 16.        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 17.        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 18.        Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 19.        Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

Figure 20.        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Europe: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)

Figure 25.        EuropeSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 26.        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 27.        Germany Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 28.        United KingdomSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 29.        FranceSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 30.        ItalySmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 31.        SpainSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 32.        Impact of COVID-19 Pandemic In European Country Markets

 

  1. Merck KGaA
  2. GlaxoSmithKline plc
  3. AstraZeneca
  4. Boehringer Ingelheim International GmbH
  5. Allergan Plc
  6. Pfizer Inc.
  7. Bristol-Myers Squibb Company
  8. Johnson & Johnson Services, Inc.
  9. Teva Pharmaceutical Industries Ltd
  • To understand the Europe small molecule drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe small molecule drug delivery market
  • Efficiently plan M&A and partnership deals in Europe small molecule drug delivery market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of Europe small molecule drug delivery market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe

Related Tags Europe Small Molecule Drug Delivery Market Europe Small Molecule Drug Delivery Market Research Europe Small Molecule Drug Delivery Market Insight Europe Small Molecule Drug Delivery Market Trends Europe Small Molecule Drug Delivery Market Forecast Europe Small Molecule Drug Delivery Market Share Europe Small Molecule Drug Delivery Market 2027 Europe Small Molecule Drug Delivery Market Growth Europe Small Molecule Drug Delivery Industry Sector Europe Small Molecule Drug Delivery PDF Report Europe Small Molecule Drug Delivery Analysis Europe Small Molecule Drug Delivery Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000